晚上福利在线观看

UCC and IPIC spin-out BioPixS to harness power of photonic phantoms

BioPixS will draw on the science of light to help develop biomedical devices and reduce animal testing in preclinical trials.

晚上福利在线观看 Cork (UCC) Innovation and the Irish Photonic Integration Centre (IPIC) have announced the launch of a new spin-out company called BioPixS. The goal of the company is to translate cutting-edge research into 鈥渋nnovative solutions to impact the biophotonics market鈥�.

IPIC is the Science Foundation Ireland research centre for photonics. It is led out of the Tyndall National Institute, a European hub for research in ICT hardware and systems based at UCC.

Photonics is the science of light and involves generating, controlling and detecting particles of light through technology. This allows researchers to study 鈥渢he universe, cure diseases and even solve crimes鈥�, according to BioPixS.

BioPixS will draw on the science of light to help develop biomedical devices and reduce animal testing in preclinical trials.

晚上福利在线观看 Cork (UCC) Innovation and the Irish Photonic Integration Centre (IPIC) have announced the launch of a new spin-out company called BioPixS. The goal of the company is to translate cutting-edge research into 鈥渋nnovative solutions to impact the biophotonics market鈥�.

IPIC is the Science Foundation Ireland research centre for photonics. It is led out of the Tyndall National Institute, a European hub for research in ICT hardware and systems based at UCC.

Photonics is the science of light and involves generating, controlling and detecting particles of light through technology. This allows researchers to study 鈥渢he universe, cure diseases and even solve crimes鈥�, according to BioPixS.

Biophotonics seeks to apply light-based technologies to life sciences and medicine. BioPixS hopes to create standards in the field through 鈥榩hantoms鈥�, which simulate light interaction in body tissue.

BioPixS was a participant in the Gateway UCC Sprint accelerator programme and was part of a consortium recently selected for European Commission  for research related to Covid-19. The spin-out is part of the Vascovid project, which is working on a portable platform for assessing microvascular health in Covid-19 patients in intensive care.

In general, the company said that its commercial products will reduce the time and costs associated with creating sophisticated biomedical devices in photonics. It also hopes to reduce the number of animals used in preclinical trials.

Dr Sanathana Konugolu Venkata Sekar, a senior researcher at Tyndall, is the CEO of BioPixS. He explained that the company鈥檚 鈥渃ommercially unique鈥� phantoms 鈥渕imic the optical properties of tissue to create a standardised approach鈥�.

鈥淥ur mission to be a one-stop solution for all biophotonics standardisation needs will spur innovation and fast-track the next generation of biomedical tools to benefit society,鈥欌�� he said.

Prof Anita Maguire, vice-president of research and innovation at UCC, added that tech driven by BioPixS will 鈥渁ccelerate instrument development and monitor day-to-day performance of devices鈥�. BioPixS is the most recent of 35 spin-out companies at UCC since 2007, she said.